Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
Wallace A, Barron J, York W, Isenberg K, Franchino-Elder J, Sidovar M, Sand M.
Wallace A, et al.
J Manag Care Spec Pharm. 2019 Oct;25(10):1102-1110. doi: 10.18553/jmcp.2019.25.10.1102.
J Manag Care Spec Pharm. 2019.
PMID: 31556820
Free PMC article.
Current evidence indicates that a high-risk and costly prodromal period, during which patients are likely symptomatic, precedes diagnosis. ...OBJECTIVE: To describe and compare HCRU and costs for up to 5 years before diagnosis in a cohort with schizophrenia versus …
Current evidence indicates that a high-risk and costly prodromal period, during which patients are likely symptomatic, precedes diagn …